Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Spine Journal : Official Journal of the North American Spine Society
|
April 29, 2014
Prospective analysis of adverse events in surgical treatment of degenerative spondylolisthesis
Adrienne M Kelly, Juliet N N Batke, Nicolas Dea, et al.
Advances in Cytopharmacology
|
January 1, 1979
Properties of Torpedo californica acetylcholine receptor
M Raftery, S Blanchard, J Elliott, et al.
The Biochemical Journal
|
March 1, 1980
Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins
J Elliott, S G Blanchard, W Wu, et al.
Contemporary Clinical Trials
|
June 5, 2016
Impact of aerobic exercise training during chemotherapy on cancer related cognitive impairments in patients suffering from acute myeloid leukemia or myelodysplastic syndrome - Study protocol of a randomized placebo-controlled trial
P Zimmer, M Oberste, W Bloch, et al.
Frontiers in Chemistry
|
October 14, 2021
Direct N-Glycosylation Profiling of Urine and Prostatic Fluid Glycoproteins and Extracellular Vesicles
Calvin R K Blaschke, Jordan P Hartig, Grace Grimsley, et al.
Journal of Medicinal Chemistry
|
February 12, 2000
4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist
L He, P J Gilligan, R Zaczek, et al.
Bioorganic & Medicinal Chemistry
|
September 1, 2000
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist
P J Gilligan, C Baldauf, A Cocuzza, et al.
Molecular Cancer Research : MCR
|
October 17, 2024
N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
Joseph E Ippolito, Jordan P Hartig, Kaitlyn Bejar, et al.
Cancer Research Communications
|
September 30, 2024
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
Jordan P Hartig, Kaitlyn Bejar, Lyndsay E A Young, et al.
Toxicology
|
December 31, 2002
Xenoendocrine disrupters-tiered screening and testing: filling key data gaps
L E Gray, J Ostby, V Wilson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Spine Journal : Official Journal of the North American Spine Society
|
April 29, 2014
Prospective analysis of adverse events in surgical treatment of degenerative spondylolisthesis
Adrienne M Kelly, Juliet N N Batke, Nicolas Dea, et al.
Advances in Cytopharmacology
|
January 1, 1979
Properties of Torpedo californica acetylcholine receptor
M Raftery, S Blanchard, J Elliott, et al.
The Biochemical Journal
|
March 1, 1980
Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins
J Elliott, S G Blanchard, W Wu, et al.
Contemporary Clinical Trials
|
June 5, 2016
Impact of aerobic exercise training during chemotherapy on cancer related cognitive impairments in patients suffering from acute myeloid leukemia or myelodysplastic syndrome - Study protocol of a randomized placebo-controlled trial
P Zimmer, M Oberste, W Bloch, et al.
Frontiers in Chemistry
|
October 14, 2021
Direct N-Glycosylation Profiling of Urine and Prostatic Fluid Glycoproteins and Extracellular Vesicles
Calvin R K Blaschke, Jordan P Hartig, Grace Grimsley, et al.
Journal of Medicinal Chemistry
|
February 12, 2000
4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist
L He, P J Gilligan, R Zaczek, et al.
Bioorganic & Medicinal Chemistry
|
September 1, 2000
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonist
P J Gilligan, C Baldauf, A Cocuzza, et al.
Molecular Cancer Research : MCR
|
October 17, 2024
N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype
Joseph E Ippolito, Jordan P Hartig, Kaitlyn Bejar, et al.
Cancer Research Communications
|
September 30, 2024
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
Jordan P Hartig, Kaitlyn Bejar, Lyndsay E A Young, et al.
Toxicology
|
December 31, 2002
Xenoendocrine disrupters-tiered screening and testing: filling key data gaps
L E Gray, J Ostby, V Wilson, et al.
Page
of 2